Quick Answer
ELITE PHARMACEUTICALS INC /NV/ reported Gross Profit of $40.09 million for fiscal year 2025.
ELITE PHARMACEUTICALS INC /NV/ Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $40.09M | +52.1% |
| 2024 | $26.36M | +58.8% |
| 2023 | $16.59M | +12.2% |
| 2022 | $14.80M | +24.7% |
| 2021 | $11.87M | +48.7% |
| 2020 | $7.98M | +178.2% |
| 2019 | $2.87M | -27.4% |
| 2018 | $3.95M | +5.6% |
| 2017 | $3.74M | -53.3% |
| 2016 | $8.01M | +300.4% |
| 2015 | $2.00M | +46.6% |
| 2014 | $1.37M | +25.4% |
| 2013 | $1.09M | -22.8% |
| 2012 | $1.41M | -11.3% |
| 2011 | $1.59M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $12.95M | +111.7% | -8.0% |
| September 30, 2025 | $14.07M | +71.7% | -48.3% |
| June 30, 2025 | $27.23M | +221.3% | +344.9% |
| December 31, 2024 | $6.12M | -13.1% | -25.4% |
| September 30, 2024 | $8.20M | +27.1% | -3.3% |
| June 30, 2024 | $8.47M | +78.4% | +20.4% |
| December 31, 2023 | $7.04M | +43.1% | +9.2% |
| September 30, 2023 | $6.45M | +68.6% | +35.7% |
- ELITE PHARMACEUTICALS INC /NV/ showed an increase of +52.1% in Gross Profit compared to the prior fiscal year.
- Over the 2011–2025 period, ELITE PHARMACEUTICALS INC /NV/’s gross profit has grown by 2419.8% (from $1.59 million to $40.09 million).
- The most recent figure is from ELITE PHARMACEUTICALS INC /NV/’s fiscal year 2024 report (Form 10-K), filed with the SEC on June 30, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: